• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙监狱中的 COVID-19 疫情:2020 年 3 月至 2022 年 6 月期间的病例特征和实施的控制措施。

COVID-19 pandemic in prisons in Spain: characteristics of cases and implemented control measures, March 2020-June 2022.

机构信息

National Center for Epidemiology, Institute of Health Carlos III, Madrid, Spain; CIBER Thematic Area of Infectious Diseases (CIBERINFEC), Madrid, Spain.

General Subdirectorate of Penitentiary Health, General Secretariat of Penitentiary Institutions, Madrid, Spain.

出版信息

Public Health. 2023 May;218:45-52. doi: 10.1016/j.puhe.2023.02.013. Epub 2023 Feb 22.

DOI:10.1016/j.puhe.2023.02.013
PMID:36965463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9943727/
Abstract

OBJECTIVES

Our aim was to describe the epidemiological characteristics of COVID-19 cases in prison inmates in Spain and the control measures implemented to response to this public health challenge.

STUDY DESIGN

Retrospective observational study.

METHODS

All COVID-19-confirmed cases reported to the Spanish information system in prisons between March 2020 and June 2022 were analyzed. Prevention plans and protocols established by penitentiary and health authorities were reviewed. Likewise, information on vaccines administered to prison inmates was described.

RESULTS

A total of 8500 COVID-19 cases were reported to penitentiary public health surveillance. The overall cumulative incidence (CI) was 2054.18 cases per 10,000 inmate population. By epidemic periods, the average weekly CI was 1.15 per 10,000 inmate population during the first period, 6.91 during the second, 25.18 during the third, 3.53 during the fourth, 23.27 during the fifth, 34.72 during the sixth and 25.68 during the seventh period. The median age of cases was 49.2 years, 69.1% was born in Spain, 64.1% was asymptomatic and 16 cases died. Ninety-four percent were vaccinated. Control measures such as lockdown, suspending visitation rights and confining inmates in their cells were adopted at the beginning of the pandemic. These measures changed in accordance with the COVID-19 situation in the general population with a view to restoring the inmates' rights.

CONCLUSION

The COVID-19 pandemic has had a moderate incidence in Spanish prisons. Hospitalization and CFR were lower than the general population. The control measures adopted against COVID-19 have contributed to preventing and controlling the number of cases in prisons.

摘要

目的

本研究旨在描述西班牙监狱囚犯中 COVID-19 病例的流行病学特征,以及为应对这一公共卫生挑战而采取的控制措施。

研究设计

回顾性观察性研究。

方法

分析了 2020 年 3 月至 2022 年 6 月期间向西班牙监狱信息系统报告的所有 COVID-19 确诊病例。审查了监狱和卫生当局制定的预防计划和方案。同样,还描述了向监狱囚犯接种的疫苗信息。

结果

向监狱公共卫生监测报告了 8500 例 COVID-19 病例。囚犯人群的总累积发病率(CI)为每 10000 名囚犯 2054.18 例。按流行期划分,第一期平均每周 CI 为每 10000 名囚犯 1.15 例,第二期为 6.91 例,第三期为 25.18 例,第四期为 3.53 例,第五期为 23.27 例,第六期为 34.72 例,第七期为 25.68 例。病例的中位年龄为 49.2 岁,69.1%出生于西班牙,64.1%无症状,16 例死亡。94%的人接种了疫苗。大流行初期,采取了封锁、暂停探视权和将囚犯禁闭在牢房等控制措施。这些措施根据一般人群中的 COVID-19 情况进行了调整,旨在恢复囚犯的权利。

结论

COVID-19 大流行在西班牙监狱中的发病率适中。住院率和病死率均低于一般人群。针对 COVID-19 采取的控制措施有助于预防和控制监狱中的病例数量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933a/9943727/6495e1e55261/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933a/9943727/e70e853bdf6d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933a/9943727/be889604cf48/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933a/9943727/6495e1e55261/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933a/9943727/e70e853bdf6d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933a/9943727/be889604cf48/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/933a/9943727/6495e1e55261/gr3_lrg.jpg

相似文献

1
COVID-19 pandemic in prisons in Spain: characteristics of cases and implemented control measures, March 2020-June 2022.西班牙监狱中的 COVID-19 疫情:2020 年 3 月至 2022 年 6 月期间的病例特征和实施的控制措施。
Public Health. 2023 May;218:45-52. doi: 10.1016/j.puhe.2023.02.013. Epub 2023 Feb 22.
2
Self-rated health impact of COVID 19 confinement on inmates in Southeastern of Europe: a qualitative study.新冠疫情禁闭对东南欧囚犯健康影响的自评:一项定性研究。
BMC Public Health. 2023 Nov 7;23(1):2183. doi: 10.1186/s12889-023-17088-3.
3
Health Management in Italian Prisons during COVID-19 Outbreak: A Focus on the Second and Third Wave.新冠疫情期间意大利监狱的健康管理:聚焦第二波和第三波疫情
Healthcare (Basel). 2022 Jan 31;10(2):282. doi: 10.3390/healthcare10020282.
4
COVID-19 - Infection prevention in prisons and jails in Poland.COVID-19 - 波兰监狱中的感染预防。
Ann Agric Environ Med. 2021 Dec 29;28(4):621-626. doi: 10.26444/aaem/140099. Epub 2021 Jul 22.
5
COVID-19 Infection Among Incarcerated Individuals and Prison Staff in Lombardy, Italy, March 2020 to February 2021.2020 年 3 月至 2021 年 2 月意大利伦巴第省被监禁者和监狱工作人员中的 COVID-19 感染。
JAMA Netw Open. 2022 Mar 1;5(3):e224862. doi: 10.1001/jamanetworkopen.2022.4862.
6
Managing COVID-19 outbreaks in prisons - a brief review of literature and key lessons learnt.管理监狱中的 COVID-19 疫情爆发:文献综述及主要经验教训。
Int J Prison Health (2024). 2024 Oct 17;ahead-of-print(ahead-of-print):410-421. doi: 10.1108/IJOPH-08-2023-0049.
7
[Regulations against the Covid-19 pandemic in spanish prisons].[西班牙监狱针对新冠疫情的规定]
Cuad Bioet. 2022 Jan-Apr;33(107):89-98. doi: 10.30444/CB.115.
8
The epidemic burden on prisons in Lombardy (Italy) during the first wave of the COVID-19 pandemic: the transmission and measures of prevention in detention facilities.意大利伦巴第大区监狱在新冠疫情第一波期间的流行负担:拘留设施中的传播情况及预防措施
Int J Prison Health. 2021 Oct 18;17(3):359-372. doi: 10.1108/IJPH-11-2020-0091. Epub 2021 Jun 17.
9
Mood and Emotions among Inmates after COVID-19 Pandemic.新冠肺炎疫情后囚犯的情绪。
Int J Environ Res Public Health. 2023 Mar 9;20(6):4856. doi: 10.3390/ijerph20064856.
10
Clinical and epidemiological characteristics of prisoners infected and deceased by COVID-19, National Penitentiary Institute of Peru, 2020.2020 年秘鲁国家监狱研究所感染和死于 COVID-19 的囚犯的临床和流行病学特征。
Rev Esp Sanid Penit. 2022 Jan-Apr;24(1):15-22. doi: 10.18176/resp.00045.

引用本文的文献

1
Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain).西班牙阿利坎特一所监狱中加强接种新冠疫苗后的血清阳性率。
Front Public Health. 2025 Jan 28;13:1490809. doi: 10.3389/fpubh.2025.1490809. eCollection 2025.
2
The effectiveness of non-exposure to incarceration in preventing COVID-19 and mitigating associated events: a systematic review and meta-analysis.非监禁暴露在预防新冠病毒病及减轻相关事件中的有效性:一项系统评价与荟萃分析
BMC Public Health. 2025 Jan 17;25(1):206. doi: 10.1186/s12889-024-20859-1.
3
The COVID-19 pandemic in Spanish prisons: epidemiology and performance evaluation.

本文引用的文献

1
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.奥密克戎和德尔塔变异株主导期间感染新型冠状病毒(SARS-CoV-2)个体的症状流行率、持续时间及住院风险:来自ZOE COVID研究的一项前瞻性观察性研究
Lancet. 2022 Apr 23;399(10335):1618-1624. doi: 10.1016/S0140-6736(22)00327-0. Epub 2022 Apr 7.
2
Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines.SARS-CoV-2 的奥密克戎变异株:基因组学、传染性,以及对当前 COVID-19 疫苗的反应。
J Med Virol. 2022 May;94(5):1825-1832. doi: 10.1002/jmv.27588. Epub 2022 Jan 23.
3
西班牙监狱中的新冠疫情:流行病学与绩效评估
Rev Esp Sanid Penit. 2024 May-Aug;26(2):47-49. doi: 10.18176/resp.00086.
4
Self-rated health impact of COVID 19 confinement on inmates in Southeastern of Europe: a qualitative study.新冠疫情禁闭对东南欧囚犯健康影响的自评:一项定性研究。
BMC Public Health. 2023 Nov 7;23(1):2183. doi: 10.1186/s12889-023-17088-3.
How COVID vaccines shaped 2021 in eight powerful charts.
新冠疫苗如何通过八张有力图表塑造了2021年。
Nature. 2021 Dec;600(7890):580-583. doi: 10.1038/d41586-021-03686-x.
4
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.2021年3月至8月美国Moderna、辉瑞-生物科技公司和杨森(强生)疫苗在预防无免疫功能低下状况成年人新冠病毒肺炎住院方面的比较效果
MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1337-1343. doi: 10.15585/mmwr.mm7038e1.
5
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.65 岁及以上成年人在初级保健中针对有症状的 SARS-CoV-2 感染的疫苗有效性:I-MOVE-COVID-19 项目,欧洲,2020 年 12 月至 2021 年 5 月。
Euro Surveill. 2021 Jul;26(29). doi: 10.2807/1560-7917.ES.2021.26.29.2100670.
6
Epidemiology of COVID-19 in Prisons, England, 2020.2020 年英格兰监狱中的 COVID-19 流行病学。
Emerg Infect Dis. 2021 Aug;27(8):2183-2186. doi: 10.3201/eid2708.204920.
7
The COVID-19 Epidemic and the Prison System in Italy.意大利的新冠疫情与监狱系统。
J Correct Health Care. 2021 Mar;27(1):3-7. doi: 10.1089/jchc.20.04.0026. Epub 2021 Feb 3.
8
Public health response to an outbreak of SARS-CoV2 infection in a Barcelona prison.巴塞罗那监狱发生 SARS-CoV2 感染疫情后的公共卫生应对措施。
Epidemiol Infect. 2021 Apr 14;149:e91. doi: 10.1017/S0950268821000789.
9
Fighting covid-19 outbreaks in prisons.抗击监狱中的新冠疫情。
BMJ. 2020 Apr 2;369:m1362. doi: 10.1136/bmj.m1362.